These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 31786671)
1. Serum starvation enhances nonsense mutation readthrough. Wittenstein A; Caspi M; David Y; Shorer Y; Nadar-Ponniah PT; Rosin-Arbesfeld R J Mol Med (Berl); 2019 Dec; 97(12):1695-1710. PubMed ID: 31786671 [TBL] [Abstract][Full Text] [Related]
2. Nonsense mutation suppression is enhanced by targeting different stages of the protein synthesis process. Wittenstein A; Caspi M; Rippin I; Elroy-Stein O; Eldar-Finkelman H; Thoms S; Rosin-Arbesfeld R PLoS Biol; 2023 Nov; 21(11):e3002355. PubMed ID: 37943958 [TBL] [Abstract][Full Text] [Related]
3. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566 [TBL] [Abstract][Full Text] [Related]
4. Readthrough of premature termination codons in the adenomatous polyposis coli gene restores its biological activity in human cancer cells. Floquet C; Rousset JP; Bidou L PLoS One; 2011; 6(8):e24125. PubMed ID: 21909382 [TBL] [Abstract][Full Text] [Related]
5. Toward a rationale for the PTC124 (Ataluren) promoted readthrough of premature stop codons: a computational approach and GFP-reporter cell-based assay. Lentini L; Melfi R; Di Leonardo A; Spinello A; Barone G; Pace A; Palumbo Piccionello A; Pibiri I Mol Pharm; 2014 Mar; 11(3):653-64. PubMed ID: 24483936 [TBL] [Abstract][Full Text] [Related]
6. A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents. Caspi M; Firsow A; Rajkumar R; Skalka N; Moshkovitz I; Munitz A; Pasmanik-Chor M; Greif H; Megido D; Kariv R; Rosenberg DW; Rosin-Arbesfeld R J Mol Med (Berl); 2016 Apr; 94(4):469-82. PubMed ID: 26620677 [TBL] [Abstract][Full Text] [Related]
7. Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations. Lebeda D; Fierenz A; Werfel L; Rosin-Arbesfeld R; Hofhuis J; Thoms S J Mol Med (Berl); 2024 May; 102(5):641-653. PubMed ID: 38430393 [TBL] [Abstract][Full Text] [Related]
8. 2-Guanidino-quinazoline promotes the readthrough of nonsense mutations underlying human genetic diseases. Bidou L; Bugaud O; Merer G; Coupet M; Hatin I; Chirkin E; Karri S; Demais S; François P; Cintrat JC; Namy O Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2122004119. PubMed ID: 35994666 [TBL] [Abstract][Full Text] [Related]
9. Translation termination codons in protein synthesis and disease. Lombardi S; Testa MF; Pinotti M; Branchini A Adv Protein Chem Struct Biol; 2022; 132():1-48. PubMed ID: 36088072 [TBL] [Abstract][Full Text] [Related]
10. Resorting the function of the colorectal cancer gatekeeper adenomatous polyposis coli. Kariv R; Caspi M; Fliss-Isakov N; Shorer Y; Shor Y; Rosner G; Brazowski E; Beer G; Cohen S; Rosin-Arbesfeld R Int J Cancer; 2020 Feb; 146(4):1064-1074. PubMed ID: 31283021 [TBL] [Abstract][Full Text] [Related]
11. Molecular Insights into Determinants of Translational Readthrough and Implications for Nonsense Suppression Approaches. Lombardi S; Testa MF; Pinotti M; Branchini A Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322589 [TBL] [Abstract][Full Text] [Related]
12. Small molecule Y-320 stimulates ribosome biogenesis, protein synthesis, and aminoglycoside-induced premature termination codon readthrough. Hosseini-Farahabadi S; Baradaran-Heravi A; Zimmerman C; Choi K; Flibotte S; Roberge M PLoS Biol; 2021 May; 19(5):e3001221. PubMed ID: 33939688 [TBL] [Abstract][Full Text] [Related]
13. Cancer syndromes and therapy by stop-codon readthrough. Bordeira-Carriço R; Pêgo AP; Santos M; Oliveira C Trends Mol Med; 2012 Nov; 18(11):667-78. PubMed ID: 23044248 [TBL] [Abstract][Full Text] [Related]
14. Induction of Translational Readthrough across the Thalassemia-Causing Premature Stop Codon in β-Globin-Encoding mRNA. Kar D; Sellamuthu K; Kumar SD; Eswarappa SM Biochemistry; 2020 Jan; 59(1):80-84. PubMed ID: 31577420 [TBL] [Abstract][Full Text] [Related]
15. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency. Frew J; Baradaran-Heravi A; Balgi AD; Wu X; Yan TD; Arns S; Shidmoossavee FS; Tan J; Jaquith JB; Jansen-West KR; Lynn FC; Gao FB; Petrucelli L; Feldman HH; Mackenzie IR; Roberge M; Nygaard HB Mol Neurodegener; 2020 Mar; 15(1):21. PubMed ID: 32178712 [TBL] [Abstract][Full Text] [Related]
16. Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells. Bidou L; Bugaud O; Belakhov V; Baasov T; Namy O RNA Biol; 2017 Mar; 14(3):378-388. PubMed ID: 28145797 [TBL] [Abstract][Full Text] [Related]
17. Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity. Baradaran-Heravi A; Niesser J; Balgi AD; Choi K; Zimmerman C; South AP; Anderson HJ; Strynadka NC; Bally MB; Roberge M Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3479-3484. PubMed ID: 28289221 [TBL] [Abstract][Full Text] [Related]
18. Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides. Wangen JR; Green R Elife; 2020 Jan; 9():. PubMed ID: 31971508 [TBL] [Abstract][Full Text] [Related]
19. Genome-scale quantification and prediction of pathogenic stop codon readthrough by small molecules. Toledano I; Supek F; Lehner B Nat Genet; 2024 Sep; 56(9):1914-1924. PubMed ID: 39174735 [TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development. Li S; Li J; Shi W; Nie Z; Zhang S; Ma F; Hu J; Chen J; Li P; Xie X Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]